Comparable brain levels of amyloid-β and tau in asymptomatic AD and mild cognitive impairment

被引：0
|
作者：
机构：
来源：
Nature Reviews Neurology | 2014年 / 10卷 / 4期
关键词：
D O I：
10.1038/nrneurol.2014.52
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 181
相关论文
共 50 条
  • [31] Down syndrome: Distribution of brain amyloid in mild cognitive impairment
    Keator, David B.
    Phelan, Michael J.
    Taylor, Lisa
    Doran, Eric
    Krinsky-McHale, Sharon
    Price, Julie
    Ballard, Erin E.
    Kreisl, William C.
    Hom, Christy
    Nguyen, Dana
    Pulsifer, Margaret
    Lai, Florence
    Rosas, Diana H.
    Brickman, Adam M.
    Schupf, Nicole
    Yassa, Michael A.
    Silverman, Wayne
    Lott, Ira T.
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [32] False Recognition Correlates with Amyloid-β1-42 but not with Total Tau in Cerebrospinal Fluid of Patients with Dementia and Mild Cognitive Impairment
    Hildebrandt, Helmut
    Haldenwanger, Andreas
    Eling, Paul
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 157 - 165
  • [33] Olfactory bulb Amyloid-β correlates with brain Thal amyloid phase and severity of cognitive impairment
    Tremblay, Cecilia
    Serrano, Geidy
    Intorcia, Anthony
    Sue, Lucia
    Arce, Richard
    Beach, Thomas
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 462 - 462
  • [34] Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment
    Tremblay, Cecilia
    Serrano, Geidy E.
    Intorcia, Anthony J.
    Mariner, Monica R.
    Sue, Lucia, I
    Arce, Richard A.
    Atri, Alireza
    Adler, Charles H.
    Belden, Christine M.
    Shill, Holly A.
    Driver-Dunckley, Erika
    Mehta, Shyamal H.
    Beach, Thomas G.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (08): : 643 - 649
  • [35] Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
    Arendash, Gary W.
    Mori, Takashi
    Cao, Chuanhai
    Mamcarz, Malgorzata
    Runfeldt, Melissa
    Dickson, Alexander
    Rezai-Zadeh, Kavon
    Tan, Jun
    Citron, Bruce A.
    Lin, Xiaoyang
    Echeverria, Valentina
    Potter, Huntington
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (03) : 661 - 680
  • [36] Plasma levels of amyloid beta peptides are altered in mild cognitive impairment (MCI) but not in Alzheimer's disease (AD)
    Sobow, T
    Kloszewska, I
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S356 - S356
  • [37] Cognitive decline in AD and mild cognitive impairment is associated with global brain damage
    van der Flier, WM
    van den Heuvel, DMJ
    Weverling-Rijnsburger, AWE
    Spilt, A
    Bollen, ELEM
    Westendorp, RGJ
    Middelkoop, HAM
    van Buchem, MA
    [J]. NEUROLOGY, 2002, 59 (06) : 874 - 879
  • [38] Meta-Analysis of Cerebrospinal Fluid Levels of Beta-Amyloid, Total Tau, and p-Tau in Patients with Mild Cognitive Impairment
    Legesse, Benalfew
    Sirbu, Cristian
    Griffith, James P.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 16 (03): : A76 - A77
  • [39] Cerebrospinal fluid TAU protein and amyloid b42 in mild cognitive impairment
    Ivanoiu, A.
    Sindic, C. J. M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 186 - 186
  • [40] Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
    Wei Hong-Chun
    Li Bing
    Ng Kok Pin
    Fu Qing-Xi
    Dong Sheng-Jie
    Ba Mao-Wen
    Kong Min
    [J]. 中华医学杂志(英文版), 2021, 134 (14) : 1709 - 1719
12345